Literature DB >> 17890471

Using the St. George respiratory questionnaire to ascertain health quality in persons with treated pulmonary tuberculosis.

Jotam G Pasipanodya1, Thaddeus L Miller, Mauricio Vecino, Guadalupe Munguia, Sejong Bae, Gerry Drewyer, Stephen E Weis.   

Abstract

INTRODUCTION: Pulmonary tuberculosis (PTB) can result in anatomic and functional changes that are associated with pulmonary impairment after tuberculosis that occurs frequently and varies in severity. We completed the St. George Respiratory Questionnaire (SGRQ), a health-related quality-of-life (HRQoL) instrument validated for several types of lung disease, for patients in whom PTB or latent tuberculosis infection (LTBI) has been diagnosed. We measured HRQoL pattern changes and the usefulness of the SGRQ in their ascertainment.
METHODS: Participants with known pulmonary function and a history of PTB or LTBI completed HRQoL questionnaires. The SGRQ was validated for content and construct using pulmonary function tests and the Medical Outcomes Study questionnaire. Internal consistency and test-retest methods assessed reliability. Significance of findings was determined with one-way analysis of variance with between-group comparisons.
RESULTS: Over 15 months, 313 subjects completed the SGRQ. The SGRQ was valid and reliable in the study population (intraclass correlation, 0.927; p<0.01; Cronbach alpha, 0.93). The mean total score for posttuberculosis patients was significantly higher than for that for LTBI score (23.5 [SE, 2.2] vs 10.3 [SE, 1.0], respectively; p<0.001).
CONCLUSIONS: We validated the SGRQ in a diverse population microbiologically cured of tuberculosis and found a mean 13.5-U difference in SGRQ score between these patients and a comparison group with similar risk factors (p<0.001). This difference indicates impairment after PTB has a substantial impact on human health worldwide. The microbiological cure of tuberculosis is not sufficient to avert chronic health loss. More aggressive treatment of LTBI and other case-preventing strategies is warranted worldwide.

Entities:  

Mesh:

Year:  2007        PMID: 17890471     DOI: 10.1378/chest.07-0755

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  39 in total

1.  Mortality hazard and survival after tuberculosis treatment.

Authors:  Thaddeus L Miller; Fernando A Wilson; Jenny W Pang; Suzanne Beavers; Sally Hoger; Sharon Sharnprapai; Melissa Pagaoa; Dolly J Katz; Stephen E Weis
Journal:  Am J Public Health       Date:  2015-03-19       Impact factor: 9.308

2.  Costs and cost-effectiveness of four treatment regimens for latent tuberculosis infection.

Authors:  David P Holland; Gillian D Sanders; Carol D Hamilton; Jason E Stout
Journal:  Am J Respir Crit Care Med       Date:  2009-03-19       Impact factor: 21.405

3.  Pulmonary impairment after tuberculosis and its contribution to TB burden.

Authors:  Jotam G Pasipanodya; Scott Jn McNabb; Peter Hilsenrath; Sejong Bae; Kristine Lykens; Edgar Vecino; Guadalupe Munguia; Thaddeus L Miller; Gerry Drewyer; Stephen E Weis
Journal:  BMC Public Health       Date:  2010-05-19       Impact factor: 3.295

4.  The association between symptoms and microbiologically defined response to tuberculosis treatment.

Authors:  Craig M Hales; Charles M Heilig; Richard Chaisson; Chi Chiu Leung; Kwok Chiu Chang; Stefan V Goldberg; Fred Gordin; John L Johnson; Grace Muzanyi; Jussi Saukkonen; Andrew Vernon; M Elsa Villarino; William J Burman
Journal:  Ann Am Thorac Soc       Date:  2013-02

5.  Long-term antifungal treatment improves health status in patients with chronic pulmonary aspergillosis: a longitudinal analysis.

Authors:  Khaled Al-Shair; Graham T Atherton; Christine Harris; Libuse Ratcliffe; Philippa J Newton; David W Denning
Journal:  Clin Infect Dis       Date:  2013-06-20       Impact factor: 9.079

6.  Patient outcomes associated with post-tuberculosis lung damage in Malawi: a prospective cohort study.

Authors:  Jamilah Meghji; Maia Lesosky; Elizabeth Joekes; Peter Banda; Jamie Rylance; Stephen Gordon; Joseph Jacob; Harmien Zonderland; Peter MacPherson; Elizabeth L Corbett; Kevin Mortimer; Stephen Bertel Squire
Journal:  Thorax       Date:  2020-02-26       Impact factor: 9.139

7.  A predictive scoring instrument for tuberculosis lost to follow-up outcome.

Authors:  Teresa Rodrigo; Joan A Caylà; Martí Casals; José M García-García; José A Caminero; Juan Ruiz-Manzano; Rafael Blanquer; Rafael Vidal; Neus Altet; José L Calpe; Antón Penas
Journal:  Respir Res       Date:  2012-09-02

8.  Psychometric testing of the short version of the world health organization quality of life (WHOQOL-BREF) questionnaire among pulmonary tuberculosis patients in Taiwan.

Authors:  Wei-Sheng Chung; Yu-Ling Lan; Ming-Chin Yang
Journal:  BMC Public Health       Date:  2012-08-09       Impact factor: 3.295

9.  Measuring health-related quality of life in tuberculosis: a systemic review--response.

Authors:  Stephen E Weis; Jotam G Pasipanodya
Journal:  Health Qual Life Outcomes       Date:  2010-01-19       Impact factor: 3.186

10.  Validity and Reliability of CAT and Dyspnea-12 in Bronchiectasis and Tuberculous Destroyed Lung.

Authors:  Bo Young Lee; Seohyun Lee; Jae Seung Lee; Jin Woo Song; Sang-Do Lee; Seung Hun Jang; Ki-Suck Jung; Yong Il Hwang; Yeon-Mok Oh
Journal:  Tuberc Respir Dis (Seoul)       Date:  2012-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.